EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, SSY Group's Enterprise Value is HK$15,713 Mil.
SSY Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was HK$222 Mil. Therefore, SSY Group's EV-to-FCF for today is 70.82.
The historical rank and industry rank for SSY Group's EV-to-FCF or its related term are showing as below:
HKSE:02005'
s EV-to-FCF Range Over the Past 10 Years
Min: -131.21 Med: 44.6 Max: 157.47
Current: 71.89
During the past 13 years, the highest EV-to-FCF of SSY Group was 157.47. The lowest was -131.21. And the median was 44.60.
HKSE:02005's EV-to-FCF is ranked worse than 83.27% of 508
companies
in the Drug Manufacturers industry
Industry Median: 23.135
vs HKSE:02005: 71.89
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-05-03), SSY Group's stock price is HK$4.78.
SSY Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.443. Therefore, SSY Group's PE Ratio for today is 10.79.
SSY Group EV-to-FCF Historical Data
The historical data trend for SSY Group's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, SSY Group's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SSY Group's EV-to-FCF Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, SSY Group's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where SSY Group's EV-to-FCF falls into.
SSY Group's current Enterprise Value is HK$15,713 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. SSY Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was HK$222 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SSY Group (HKSE:02005) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
SSY Group's share price for today is HK$4.78.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. SSY Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.443.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
SSY Group EV-to-FCF Related Terms
Thank you for viewing the detailed overview of SSY Group's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
SSY Group Ltd is engaged in the research, development, manufacturing and selling of a wide range of pharmaceutical products, which includes finished medicines of mainly intravenous infusion solution and ampoule injection to hospitals and distributors, bulk pharmaceuticals and medical materials. The company has two reportable segments including intravenous infusion solution and others and medical materials. The company derives a vast majority of its revenue principally from the Intravenous infusion solution and others. Revenue generation is driven mostly by its sales of pharmaceutical products, followed by medical materials.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:02005 has been successfully added to your 